Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Population Pharmacokinetics (PK) of Melphalan in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT03609827 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03609827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Population Pharmacokinetics (PK) of Melphalan in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
September 1, 2015
Completion date
May 31, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fanconi's anemia, genetic inborn errors of metabolism, hematologic malignancies, hemoglobinopathies, immunodeficiencies, nonmalignant diseases, sickle cell disease, thalassemia